Qube Research & Technologies (QRT)
TERN

Qube Research & Technologies (QRT)’s Terns Pharmaceuticals TERN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.4M Buy
537,884
+530,220
+6,918% +$21.8M 0.03% 683
2025
Q4 		$310K Sell
7,664
-69,118
-90% -$1.6M ﹤0.01% 2943
2025
Q3 		$577K Sell
76,782
-259,883
-77% -$1.66M ﹤0.01% 2683
2025
Q2 		$1.26M Sell
336,665
-358,494
-52% -$1.12M ﹤0.01% 2379
2025
Q1 		$1.92M Buy
695,159
+380,770
+121% +$1.55M ﹤0.01% 1971
2024
Q4 		$1.74M Sell
314,389
-142,550
-31% -$965K ﹤0.01% 1941
2024
Q3 		$3.81M Buy
+456,939
New +$3.76M 0.01% 1520
2023
Q2 		– Sell
-50,951
Closed -$603K – 3003
2023
Q1 		$603K Buy
50,951
+40,406
+383% +$386K ﹤0.01% 1497
2022
Q4 		$107K Sell
10,545
-264
-2% -$1.76K ﹤0.01% 1991
2022
Q3 		$64K Sell
10,809
-599
-5% -$2.23K ﹤0.01% 2084
2022
Q2 		$28K Buy
+11,408
New +$22.8K ﹤0.01% 2218

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TERN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Terns Pharmaceuticals (TERN) stake by 6,918% in Q1 2026, buying an estimated $21.8M and bringing the position to 537,884 shares worth $28.4M. The position accounts for 0.03% of the portfolio, ranked #683.

Qube Research & Technologies (QRT) first reported a position in TERN in Q2 2022 and has held it in 11 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 537,884 shares of Terns Pharmaceuticals worth $28.4M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 530,220 Terns Pharmaceuticals shares in Q1 2026, an estimated $21.8M.
  • Terns Pharmaceuticals made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #683 holding.
  • Qube Research & Technologies (QRT) first reported a position in Terns Pharmaceuticals in Q2 2022 and has held it in 11 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.